The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans

This study has been completed.

Sponsors and Collaborators:	Weill Medical College of Cornell University National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:	NCT00227201

Purpose

The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure.

Condition	Intervention
Hypertension	Behavioral: Self-affirmation intervention

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Observational
Official Title:	The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:

The impact of positive affect induction and self-affirmation on medication adherence and blood pressure control.

Estimated Enrollment:	60
Study Start Date:	June 2003
Estimated Study Completion Date:	May 2005

Detailed Description:

The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure. Through the use of qualitative interviews, the beliefs and attitudes toward complementary medicine of African Americans with hypertension will be elucidated.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients will be African-American adults 18 years or older who were diagnosed with poorly controlled hypertension as defined by the 6th Joint National Committee guidelines (systolic >140 and diastolic >90).
Patients will also be eligible if they are taking any prescribed anti-hypertensive medications.
Patients must be able to provide informed consent in English. Participants will be recruited from Cornell Internal Medicine Associates, the primary care and general medicine practice at Cornell Medical Center, the same site as the parent grant.

Exclusion Criteria:

Patients who refused to participate.
Patients who are unable to provide informed consent.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00227201

Locations

United States, New York
New York Presbyterian Hospital-Weill Medical College
New York, New York, United States, 10021

Sponsors and Collaborators

Weill Medical College of Cornell University

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Principal Investigator:	Jason Moore	Weill Medical College of Cornell University
Principal Investigator:	Mary E Charlson, MD	Weill Medical College of Cornell University

More Information

Study ID Numbers:	0301005948
Study First Received:	September 23, 2005
Last Updated:	April 23, 2008
ClinicalTrials.gov Identifier:	NCT00227201
Health Authority:	United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:

African-American
Hypertension
Complementary medicine
Medication adherence

Study placed in the following topic categories:

Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009